Literature DB >> 17418803

Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.

Auinash Kalsotra1, Sayeepriyadarshini Anakk, Chad L Brommer, Yasushi Kikuta, Edward T Morgan, Henry W Strobel.   

Abstract

Cytochrome P450 (CYP) 4F mediated leukotriene B(4) (LTB(4)) metabolism modulates inflammation during injury and infection. Here we show that in addition to LTB(4), the recombinant rat CYP4Fs catalyze omega-hydroxylations of lipoxin A(4), and hydroxyeicosatetraeonic acids. CYP4F gene regulation studies in primary hepatocytes reveal that pro-inflammatory cytokines interleukin (IL) -1beta, IL-6 and tumor necrosis factor (TNF) -alpha produce a general inductive response whereas IL-10, an anti-inflammatory cytokine, suppresses CYP4F expression. The molecular mechanism behind IL-6 related induction of CYP4F4 and 4F5 is partially signal transducer and activator of transcription 3 (STAT3) dependent. When hepatocytes are subjected to high concentrations of LTB(4) or prostaglandin E(2), lipid mediators of inflammation, only an increase in CYP4F5 mRNA expression is observed. Collectively, the results from isozyme activity and substrate driven CYP4F induction do not support the notion that an autoregulatory pathway could control the excessive concentrations of LTB(4) during an inflammatory challenge to hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418803      PMCID: PMC2574503          DOI: 10.1016/j.abb.2007.02.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  53 in total

1.  Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain.

Authors:  H Kawashima; E Kusunose; C M Thompson; H W Strobel
Journal:  Arch Biochem Biophys       Date:  1997-11-01       Impact factor: 4.013

2.  Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.

Authors:  E J Goetzl; A R Brash; A I Tauber; J A Oates; W C Hubbard
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

Review 3.  Regulation of cytochromes P450 during inflammation and infection.

Authors:  E T Morgan
Journal:  Drug Metab Rev       Date:  1997-11       Impact factor: 4.518

Review 4.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

5.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

6.  Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes.

Authors:  Fengyun Xu; John R Falck; Paul R Ortiz de Montellano; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2003-11-21       Impact factor: 4.030

7.  Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells.

Authors:  Yasushi Kikuta; Yoshiaki Yamashita; Soichiro Kashiwagi; Kazunori Tani; Kazushi Okada; Kiyofumi Nakata
Journal:  Biochim Biophys Acta       Date:  2004-07-05

8.  Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids.

Authors:  Auinash Kalsotra; Cheri M Turman; Yasushi Kikuta; Henry W Strobel
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

9.  Purification and characterization of recombinant human neutrophil leukotriene B4 omega-hydroxylase (cytochrome P450 4F3).

Authors:  Y Kikuta; E Kusunose; H Sumimoto; Y Mizukami; K Takeshige; T Sakaki; Y Yabusaki; M Kusunose
Journal:  Arch Biochem Biophys       Date:  1998-07-15       Impact factor: 4.013

10.  Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney.

Authors:  Auinash Kalsotra; Xiaoming Cui; Leposava Antonovic; Aaron M Robida; Edward T Morgan; Henry W Strobel
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

View more
  9 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.

Authors:  Venkata R Narala; Ravi K Adapala; Madathilparambil V Suresh; Thomas G Brock; Marc Peters-Golden; Raju C Reddy
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

3.  Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients.

Authors:  Jiazhen Xing; Xiaoqing Zhang; Junwei Fan; Bin Shen; Tongyi Men; Jianning Wang
Journal:  Eur J Clin Pharmacol       Date:  2014-12-10       Impact factor: 2.953

Review 4.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

Review 5.  Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology.

Authors:  Daniel W Nebert; Christopher L Karp
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

6.  20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells.

Authors:  Liping Du; Huiyong Yin; Jason D Morrow; Henry W Strobel; Diane S Keeney
Journal:  Arch Biochem Biophys       Date:  2009-01-20       Impact factor: 4.013

7.  The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients.

Authors:  Zhaolin Chen; Xi Cheng; Liwen Zhang; Liqin Tang; Yan Fang; Hongxiao Chen; Lei Zhang; Aizong Shen
Journal:  Pharmacol Rep       Date:  2021-06-05       Impact factor: 3.024

8.  Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection.

Authors:  Neha Sehgal; Kanhaiya Lal Kumawat; Anirban Basu; Vijayalakshmi Ravindranath
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways.

Authors:  Hirotada Kobayashi; Karin Amrein; Jessica A Lasky-Su; Kenneth B Christopher
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.